Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023

SELL
$5.76 - $12.48 $11 - $24
-2 Reduced 0.2%
1,000 $6.93 Million
Q3 2022

Jan 19, 2023

SELL
$18.2 - $76.12 $18,200 - $76,120
-1,000 Reduced 49.95%
1,002 $18.2 Million
Q2 2022

Jan 19, 2023

SELL
$36.28 - $75.29 $362 - $752
-10 Reduced 0.5%
2,002 $103 Million
Q1 2022

Jan 19, 2023

SELL
$69.73 - $142.9 $139,460 - $285,800
-2,000 Reduced 49.85%
2,012 $148 Million
Q4 2021

Jan 19, 2023

BUY
$134.56 - $217.97 $539,854 - $874,495
4,012 New
4,012 $574 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $594M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Stephens Consulting, LLC Portfolio

Follow Stephens Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.